Inhibition of testosterone 5 alpha-reductase by a proposed enzyme-activated, active site-directed inhibitor.
Inhibition of testosterone 5 alpha-reductase by a proposed enzyme-activated, active site-directed inhibitor.
复制标题
所提出的酶激活活性定点抑制剂对睾酮 5 α 还原酶的抑制作用。
DOI:
10.1016/0006-291x(80)90735-4
复制
发表时间:
1980
影响因子:
3.1
通讯作者:
G. L. Schatzman
中科院分区:
文献类型:
--
作者:
T. R. Blohm;B. Metcalf;M. Laughlin;A. Sjoerdsma;G. L. Schatzman
RMI 18,341 (5α,20-R)-4-diazo-21-hydroxy-20-methylpregnan-3-one, was designed to be an enzyme-activated irreversible inhibitor of testosterone 5α-reductase. It produced time-dependent, apparently first-order inactivation of the enzyme, which can be antagonized by substrate, indicative of irreversible inactivation occurring at the enzyme active site. Unlike conventional 5α-steroids, RMI 18,341 has a high affinity for the enzyme:apparent Ki= 3.5 × 10−8M. At 25°C, formation of the reversible EI complex is not rate-limiting for enzyme inactivation, and this is expressed as saturation kinetics for the inhibition reaction. RMI 18,341 produces no inhibition of 3α-hydroxysteroid oxidoreductase of rat prostate, in contrast to other 3-keto-5α-steroids. The specificity, irreversibility and high affinity for testosterone 5α-reductase should make RMI 18,341 a useful tool in elucidation of the physiological roles of testosterone metabolites.